Literature DB >> 28838983

DLCO: adjust for lung volume, standardised reporting and interpretation.

Douglas C Johnson1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28838983     DOI： 10.1183/13993003.00940-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.

Authors:  D C Johnson
Journal:  Respir Med       Date:  2000-01       Impact factor: 3.415

2.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

Review 3.  Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components.

Authors:  J Michael B Hughes; Neil B Pride
Journal:  Am J Respir Crit Care Med       Date:  2012-04-26       Impact factor: 21.405

4.  2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.

Authors:  Brian L Graham; Vito Brusasco; Felip Burgos; Brendan G Cooper; Robert Jensen; Adrian Kendrick; Neil R MacIntyre; Bruce R Thompson; Jack Wanger
Journal:  Eur Respir J       Date:  2017-01-03       Impact factor: 16.671
  4 in total
  3 in total

1.  Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.

Authors:  Alessandro N Franciosi; Brian D Hobbs; Oliver J McElvaney; Kevin Molloy; Craig Hersh; Louise Clarke; Cedric Gunaratnam; Edwin K Silverman; Tomás P Carroll; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

Review 2.  Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective.

Authors:  Diana E Amariei; Neal Dodia; Janaki Deepak; Stella E Hines; Jeffrey R Galvin; Sergei P Atamas; Nevins W Todd
Journal:  Medicina (Kaunas)       Date:  2019-09-10       Impact factor: 2.430

3.  Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis.

Authors:  Rutkowska Elżbieta; Kwiecień Iwona; Bednarek Joanna; Jahnz-Różyk Karina; Rzepecki Piotr
Journal:  BMC Pulm Med       Date:  2020-11-20       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.